Compile Data Set for Download or QSAR
maximum 50k data
Found 4561 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase receptor UFO'
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180278(US9133162, Example 9)
Affinity DataIC50:  5nMpH: 7.0 T: 2°CAssay Description:Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180273(US9133162, Example 4)
Affinity DataIC50:  17nMpH: 7.0 T: 2°CAssay Description:Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM180270(US9133162, Example 1)
Affinity DataIC50:  11nMpH: 7.0 T: 2°CAssay Description:Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM236557(US9365572, 5)
Affinity DataIC50:  2.14E+3nMpH: 7.5 T: 2°CAssay Description:Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153643(US8999982, Ref6)
Affinity DataIC50:  8.29E+3nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153644(US8999982, Ref7)
Affinity DataIC50:  9.30E+3nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153645(US8999982, 4-((6,7-dimethoxyquinolin-4- yl)oxy)-3-...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153646(US8999982, 4-((6,7-dimethoxyquinolin-4- yl)oxy)ani...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153647(US8999982, 4-((6,7-dimethoxyquinolin-4- yl)oxy)-3-...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153648(US8999982, 3-chloro-4-((6,7- dimethoxyquinolin-4- ...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153649(US8999982, 5-((6,7-dimethoxyquinolin-4- yl)oxy)pyr...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153650(US8999982, 4-((6,7-dimethoxyquinolin-4- yl)oxy)-2-...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153651(US8999982, 4-((6,7-dimethoxyquinolin-4- yl)oxy)-2-...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153652(US8999982, 3-fluoro-4-((6-methoxy-7-(3- morpholino...)
Affinity DataIC50:  8.50E+3nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153653(US8999982, tert-butyl 4-(((4-(4-amino-2- fluorophe...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153642(US8999982, Ref5)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153641(US8999982, Ref4)
Affinity DataIC50:  7.04E+3nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153640(US8999982, Ref3)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM50317324(CHEMBL1087984 | N-(4-(6,7-dimethoxyquinolin-4-ylox...)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM153639(US8999982, Ref2)
Affinity DataIC50: >1.00E+4nMpH: 8.0Assay Description:The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299749(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0100nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299902(6-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0120nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299975(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0120nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300011(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300079(N-[(2R)-1- hydroxypropan-2- yl]-6-[4-(4- methoxy-1...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300077(N-(3-amino-3- methylbutan- 2-yl)-2- (cyclo- propyl...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300035(2-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Affinity DataKi: <0.0130nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300088(N-[(2R)-1- hydroxypropan-2- yl]-2-[(2R)-2- methoxy...)
Affinity DataKi:  0.0140nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299998(N-[(2R)-1- hydroxypropan-2- yl]-6-[4-(4- methoxy-1...)
Affinity DataKi:  0.0150nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299931(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0150nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299744(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0160nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299909(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0160nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300012(N-(2- methoxyethyl)-6- [4-(4-methoxy-1H- pyrrolo[2...)
Affinity DataKi:  0.0160nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300049((3,3- difluoroazetidin-1- yl)(2-{[(2R)-1- methoxyp...)
Affinity DataKi:  0.0180nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300007(2-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 1-hydro...)
Affinity DataKi: <0.0180nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299893(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0190nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300090(N-[(2R)-1- hydroxypropan-2- yl]-2-[(2S)-2- methoxy...)
Affinity DataKi:  0.0200nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299917(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0200nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300070(N-[(2R)-3- hydroxy-3- methylbutan-2-yl]- 4-[4-(4-m...)
Affinity DataKi:  0.0200nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299996(4-[(1- cyanocyclopropyl) methoxy]-6-[4-(4- methoxy...)
Affinity DataKi:  0.0210nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300125(N-cyclobutyl-4- {[(2R)-1- methoxypropan-2- yl]oxy}...)
Affinity DataKi:  0.0210nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299901(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0210nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300104(4-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Affinity DataKi:  0.0250nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299891(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0260nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300064(N-[(2R)-1- hydroxypropan-2- yl]-4-{[(2R)-1- methox...)
Affinity DataKi:  0.0280nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299746(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0280nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299890(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0280nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299930(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Affinity DataKi:  0.0290nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM300103(4-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 1-hydro...)
Affinity DataKi:  0.0300nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor UFO(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM299803(N- (bicyclo[1.1.1]pent- 1-yl)-4-{[(1S,2R)- 2- cyan...)
Affinity DataKi:  0.0300nMAssay Description:AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 4561 total ) | Next | Last >>
Jump to: